Pharmacologic treatments for covid-19 patients
Leflunomide + Interferon alpha2a vs Interferon alpha2a
This comparison will not be updated. Last search date 14 Dec, 2022
Hospitalized patients
Forest plots
(last update: 2021-06-18)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=93
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| ChiCTR2000030058 Wang M, Clin Infect Dis, 2020 Full text Commentary |
Public/non profit |
Leflunomide + Interferon alpha 2a |
Interferon alpha 2a |
RCT | Patients with confirmed COVID-19 (mild) admitted to a single center China | N=50 |
Some concerns Details |
|